ReviewCancer management and research2026
HER2-Targeted Antibody-Drug Conjugates in Advanced HER2-Low Breast Cancer: Mechanisms, Clinical Efficacy, and Resistance Strategies.
Mengsha Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.